Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,223 public trials 1,013 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

Erlotinib in Patients With Resected, Early Stage NSCLC With Confirmed Mutations in the EGFR

NCT00567359

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Stanford University Stanford, California, United States
  • Massachusetts General Hosptial Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Phase II Safety and Tolerability Trial With Nab-Paclitaxel Plus Carboplatin Followed by Nab-Paclitaxel for First Line Treatment of NSCLC Subjects With ECOG PS 2

NCT02289456

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • University Cancer Institute Boynton Beach, Florida, United States
  • Ochsner Clinic Nephrology New Orleans, Louisiana, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • University of RochesterJames P. Wilmont Cancer Center Rochester, New York, United States
View Trial Details
Completed

LUME-Lung 1: BIBF 1120 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Small Cell Lung Cancer

NCT00805194

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • LKH-Univ. Hospital Graz Graz, Austria
  • KH St. Vinzenz, Zams, Int. Abtlg. Kufstein, Austria
  • AKH d. Stadt Linz, Pulmologie Linz, Austria
  • Bobruisk Inter-distict Babruysk, Belarus
View all 210 locations
View Trial Details
Completed

A Study of the Safety, Tolerability, and Effects of Cobimetinib and GDC-0994 in Patients With Locally Advanced or Metastatic Solid Tumors

NCT02457793

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +27 more
Locations
  • University of Colorado Aurora, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Completed

Nivolumab in the Real World: Analysis of the Expanded Use in Spanish Patient

NCT03132493

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Hospital Virgen de los Lirios Alcoy, Alicante, Spain
  • Hospital de Elche Elche, Alicante, Spain
  • Hospital Universitario de Vinalopó Elche, Alicante, Spain
  • Hospital General Universitario de Elda Elda, Alicante, Spain
View all 61 locations
View Trial Details
Completed

Disease Characteristics, Treatment Patterns and Clinical Outcomes in Patients With Newly Diagnosed Unresectable Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) in China

NCT02458651

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Cancer Hospital Chinese Academy of Medical Sciences. Beijing, China
  • the First Hospital of Jilin University Changchun, China
  • Sichuan Provincial Cancer Hospital Chengdu, China
  • Third Affiliated Hospital of Third Military Medical University Chongqing, China
View Trial Details

Related conditions